<unk>  is a chimeric monoclonal antibody that binds to interleukin-6 (IL-6), preventing binding to soluble and membrane bound interleukin-6 receptors.<unk>  interferes with IL-6 mediated growth of B-lymphocytes and plasma cells, secretion of vascular endothelial growth factor (VEGF) and autoimmune phenomena.
Siltuximab
Dinutuximab
Margetuximab
Isatuximab
Loncastuximab tesirine
Alirocumab
Blinatumomab
Daratumumab